PRKCD and Alzheimer disease: For example, the enhanced activity of PKCα exacerbates the symptoms of AD, while the enhanced activities of subtypes such as PKCη, PKCδ and PKCε reduce the accumulation of Aβ and improve the symptoms of AD.